According to the recent report by IMARC Group, titled “Flow Cytometry Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” the global flow cytometry market reached a value of US$ 4.9 Billion in 2021. Flow cytometry is a laser-based technology that analyses the physical and chemical characteristics of cells or particles. This technology enables researchers to simultaneously conduct a multi-paramedic analysis of a group of cells. Flow cytometry subclassifies cell types and detects the residual levels of disease, which aids in developing an appropriate treatment plan for a patient. On account of these functionalities, this technology is applied for chromosome analysis, cancer diagnosis, cell sorting, and protein expression in clinical practices, trials, and research.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Flow Cytometry Market Trends:
One of the key factors driving the market growth is the increasing prevalence of various chronic diseases, such as cancer and HIV-AIDS. Flow cytometry provides toxicity testing and a rapid prognosis is required in such cases, which, in turn, is supporting the market growth. The rising adoption of stem cell therapy is acting as another major growth-inducing factor. Additionally, the increasing application of flow cytometry for cell sorting, antibody production, proliferation assays, and immunophenotyping is creating a positive outlook for the market. Various technological advancements, such as the integration of artificial intelligence (AI) with flow cytometry devices, are contributing to the market growth. Other growth-inducing factors include improving healthcare infrastructure and the widespread adoption of flow cytometry in clinical trials and other research activities. On account of these factors, the market is expected to grow at a CAGR of
8.4% during 2022-2027.
- Based on the product and service, the market has been divided into instruments, reagents and consumables, accessories, software, and services.
- On the basis of the technology, the market has been bifurcated into cell-based and bead-based flow cytometry.
- Based on the application, the market has been classified into oncology, drug discovery, disease diagnosis, stem cell therapy, organ transplantation, hematology, and others.
- On the basis of the end-user, the market has been divided into hospitals and clinics, academic and research institutes, pharmaceutical and biotechnology companies, and others.
- Region-wise, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
- The competitive landscape of the market has been analyzed in the report, with some of the key players being Agilent Technologies Inc., Apogee Flow Systems Ltd., BD (Becton, Dickinson and Company), Beckman Coulter Inc. (Danaher Corporation), Bio-RAD Laboratories Inc., Enzo Life Sciences Inc., Luminex Corporation, Merck KGaA, Sony Biotechnology Inc., Sysmex Partec GmbH, and Thermo Fisher Scientific Inc.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Follow us on twitter: @imarcglobal